Pacira Pharmaceuticals's total assets for Q3 2025 were $1.30B, a decrease of -15.59% from the previous quarter. PCRX total liabilities were $570.36M for the fiscal quarter, a -26.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.